Morphological analysis Incidence counts for new treatment-emergent morphological abnormalities were also summarized using the following categories for clinical interpretation of the ECGs: normal ECG [sinus rhythm between 50 and 100 bpm with normal P waves, atrioventricular (AV) conduction, QRS complex and ST segment, and T-wave morphologies]; new (i.e., not present at baseline) abnormal ECG findings, probably nonsignificant; abnormal ECG, possibly significant; or unreadable ECG.
← all excerpts
Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies.
1
—
—